In The News Posted January 19, 2021 Share Posted January 19, 2021 PHOENIX, Jan. 19, 2021 /PRNewswire/ -- (OTC: CELZ) Creative Medical Technology Holdings announced positive data and filing of a patent application covering the use of ImmCelz® in prevention and regression of type 1 diabetes. In a series of experiments using the non-obese diabetic model,...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.